VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
FMS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
FMSFresenius Medical Care AG & Co. KGaA
$23.40$12.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFMSQuarterly Financials

Fresenius Medical Care AG & Co. KGaA (FMS) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Fresenius Medical Care AG & Co. KGaA (FMS) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

FMS Income Statement

Quarterly statement

FMS Income Statement

Fresenius Medical Care AG & Co. KGaA (FMS) annual income statement — 28-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue4.94B4.86B4.61B5.07B4.88B4.79B4.88B5.08B4.76B4.77B4.72B4.99B4.94B4.83B4.7B5B5.1B4.76B4.55B4.65B
Revenue Growth %1.06%1.44%-5.52%-0.3%2.62%0.54%3.32%1.94%-3.56%-1.22%0.44%-0.18%-3.14%1.44%3.42%7.53%14.74%10.1%8.03%5.61%
Cost of Goods Sold3.66B3.55B3.43B3.68B3.64B3.58B3.7B3.81B3.61B3.6B3.55B3.64B3.71B3.63B3.56B3.65B3.85B3.51B3.37B3.33B
COGS % of Revenue74.17%73.05%74.43%72.61%74.57%74.66%75.75%75.02%75.92%75.53%75.16%72.94%75.1%75.19%75.57%73.03%75.6%73.81%74.19%71.61%
Gross Profit1.28B1.31B1.18B1.39B1.24B1.21B1.18B1.27B1.15B1.17B1.17B1.35B1.23B1.2B1.15B1.35B1.24B1.25B1.17B1.32B
Gross Margin %25.83%26.95%25.57%27.39%25.43%25.34%24.25%24.98%24.08%24.46%24.84%27.06%24.9%24.81%24.43%26.97%24.4%26.19%25.81%28.39%
Gross Profit Growth %2.67%7.87%-0.38%9.28%8.39%4.15%0.88%-5.87%-6.75%-2.59%2.15%0.16%-1.17%-3.9%-2.12%2.15%-1.87%-2.99%-2.72%-2.19%
Operating Expenses900.74M844.13M803.94M839.39M740.5M819.96M802.25M871.49M683.39M741M927.64M922.01M905M840M888M995.59M771.85M905.05M826.19M870.01M
OpEx % of Revenue18.25%17.37%17.43%16.56%15.16%17.11%16.43%17.14%14.36%15.55%19.63%18.48%18.33%17.41%18.88%19.92%15.15%19.03%18.16%18.72%
Selling, General & Admin743.6M736.01M748.94M784.62M705.44M791.98M750.69M839.56M756.15M771M775.64M845.16M794M775M782M954.3M817.18M757.95M789.97M823.21M
SG&A % of Revenue15.06%15.14%16.24%15.48%14.44%16.53%15.38%16.51%15.88%16.18%16.42%16.94%16.09%16.06%16.62%19.1%16.04%15.93%17.37%17.71%
Research & Development41.4M39.63M38.31M38.63M37.75M38.12M43.48M50.06M40.05M46M47.8M65.98M53M57M56M62.05M61.48M55.42M49.67M67.76M
R&D % of Revenue0.84%0.82%0.83%0.76%0.77%0.8%0.89%0.98%0.84%0.97%1.01%1.32%1.07%1.18%1.19%1.24%1.21%1.17%1.09%1.46%
Other Operating Expenses1000K1000K1000K1000K-1000K-1000K1000K-1000K-1000K-1000K1000K1000K1000K1000K1000K-1000K-1000K1000K-1000K-1000K
Operating Income374.64M465.86M375.56M548.98M501.72M394.4M381.73M398.93M462.7M425M246.01M427.65M324M357M261M351.93M471.64M340.51M347.67M449.15M
Operating Margin %7.59%9.58%8.14%10.83%10.27%8.23%7.82%7.85%9.72%8.92%5.21%8.57%6.56%7.4%5.55%7.04%9.25%7.16%7.64%9.67%
Operating Income Growth %-25.33%18.12%-1.62%37.61%8.43%-7.2%55.17%-6.71%42.81%19.05%-5.74%21.51%-31.3%4.84%-24.93%-21.65%-6.54%-19.73%-26.69%-2.69%
EBITDA400.13M828.97M838.5M922.53M858.98M769.64M776.09M875.93M828.95M812M758.46M853.58M778M791M698.81M846.61M973.63M762.51M766.63M886.26M
EBITDA Margin %8.11%17.05%18.18%18.2%17.58%16.06%15.9%17.23%17.41%17.04%16.05%17.11%15.76%16.39%14.86%16.94%19.11%16.03%16.85%19.07%
EBITDA Growth %-53.42%7.71%8.04%5.32%3.62%-5.22%2.33%2.62%6.55%2.65%8.53%0.82%-20.09%3.74%-8.85%-4.47%7.29%-6.98%-11.11%-15.07%
D&A (Non-Cash Add-back)0363.11M462.94M373.55M357.26M375.24M394.36M477M366.26M387M512.44M425.93M454M434M437.81M494.67M501.98M422M418.96M437.11M
EBIT400.13M465.86M300.82M607.48M495.66M447.13M346.37M280.13M479.63M443M261.68M454.51M349M381M273M376.69M487.69M353.26M361.78M477.51M
Net Interest Income-81.46M-82.86M-78.68M-85.39M-73.94M-74.73M-80.74M-79.47M-82M-85M-88.19M-84.59M-89M-81M-83M-75.31M-76.48M-71.58M-69.1M-66.71M
Interest Income16.05M14.7M14.62M13.62M19.16M21.85M14.98M21.57M17M18M15.66M26.87M25M24M12M24.75M16.05M12.75M14.11M28.36M
Interest Expense97.5M97.55M93.3M99.02M93.1M96.58M95.72M101.04M99M103M103.85M111.46M114M105M95M100.07M92.53M84.33M83.21M95.07M
Other Income/Expense-72.01M-82.86M-168.04M-40.51M-99.15M-43.85M-131.07M-219.82M-82.17M-85M-88.19M-84.59M-89M-81M-83M-75.31M-76.48M-71.58M-69.1M-66.71M
Pretax Income302.63M383M207.52M508.46M402.57M350.55M250.65M179.12M380.53M340M157.83M343.06M235M276M178M276.62M395.16M268.93M278.57M382.44M
Pretax Margin %6.13%7.88%4.5%10.03%8.24%7.32%5.13%3.52%7.99%7.13%3.34%6.88%4.76%5.72%3.78%5.54%7.75%5.65%6.12%8.23%
Income Tax77.83M89.83M42.75M106.44M75.22M78.26M61.05M61M116.53M99M39.51M86.46M88M81M45M83.04M112.23M62.93M66.77M78.7M
Effective Tax Rate %25.72%23.45%20.6%20.93%18.69%22.32%24.35%34.06%30.62%29.12%25.03%25.2%37.45%29.35%25.28%30.02%28.4%23.4%23.97%20.58%
Net Income159.78M218.38M117.53M327.08M274.8M225.27M151.22M66.9M213.03M187M70.96M187.93M84M140M86M138.8M230.1M147.14M157.36M228.74M
Net Margin %3.24%4.49%2.55%6.45%5.63%4.7%3.1%1.32%4.48%3.92%1.5%3.77%1.7%2.9%1.83%2.78%4.52%3.09%3.46%4.92%
Net Income Growth %-41.86%-3.06%-22.28%388.91%29%20.47%113.11%-64.4%153.6%33.57%-17.49%35.39%-63.49%-4.85%-45.35%-39.32%-15.73%-32.68%-36.79%29.1%
Net Income (Continuing)224.79M293.17M164.76M402.02M327.34M272.3M189.61M118.12M263.99M241M118.31M256.6M147M195M133M193.58M282.93M206M211.81M303.74M
Discontinued Operations00000000000000000000
Minority Interest964.81M974.54M962.88M0959.61M1.06B1.13B1.19B1.17B1.26B1.22B1.21B1.43B1.4B1.4B1.46B1.68B1.4B1.3B1.28B
EPS (Diluted)0.310.410.220.570.470.390.260.060.190.160.060.220.100.160.100.120.200.130.140.26
EPS Growth %-34.04%5.13%-15.38%850%147.37%143.75%333.33%-72.73%100%0%-40%83.33%-52.5%23.08%-28.57%-53.85%-35.48%-48%-50%30%
EPS (Basic)0.310.410.220.570.470.390.260.060.190.160.060.220.100.160.100.120.200.130.140.26
Diluted Shares Outstanding524M539.2M550.44M571.81M584.67M586.83M586.83M1.17B1.17B1.17B1.17B879.91M879.91M879.91M879.91M1.17B1.17B1.17B1.17B887.33M
Basic Shares Outstanding525.9M539.2M550.44M571.81M584.67M586.83M586.83M1.17B1.17B1.17B1.17B880.02M880.02M880.02M880.02M1.17B1.17B1.17B1.17B888.24M
Dividend Payout Ratio---0.67%-187.56%---186.72%---234.73%---268.83%--